Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | GSTM2 | P28161 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.35 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1982550 | 0.90 | ALDH1A1 (0.44) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL5115689 | 0.84 | ALDH1A1 (0.45) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL3050464 | 0.83 | ALDH1A1 (0.42) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL27658733 | 0.81 | ALDH1A1 (0.41) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL27608929 | 0.79 | ALDH1A1 (0.44) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL12343951 | 0.79 | ALDH1A1 (0.46) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL3329624 | 0.78 | CYP1A2 (0.57) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL3329616 | 0.78 | CYP1A2 (0.57) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL27933490 | 0.78 | ALDH1A1 (0.41) | ALDH1A1HTTRAB9AMAPTMEN1 | |
| SCHEMBL14705521 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HTTRAB9AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120276051-A1 | INHIBITORS OF HEPATITIS C VIRUS | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276051-A1 | INHIBITORS OF HEPATITIS C VIRUS | HAVCR2, LIPC, HCCS | ALDH1A1 1654/4885HTT 4258/4885RAB9A 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.